Načítá se...
(68)Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study
This prospective pilot study investigated the value of (68)Ga-NOTA-RM26, an antagonist targeting gastrin-releasing peptide receptor (GRPR), in evaluation of breast cancer. METHODS: Thirty-five women in suspicion of breast cancer based on mammography or ultrasonography were recruited with informed co...
Uloženo v:
| Vydáno v: | Clin Nucl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6076351/ https://ncbi.nlm.nih.gov/pubmed/30036253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLU.0000000000002209 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|